Ivermectin Prophylaxis Used for COVID-19: A Citywide, Prospective

Lucy Kerr • Flavio A. Cadegiani • Fernando Baldi • et. al., DOI: 10.7759/cureus.21272  Abstract Background: Ivermectin has demonstrated different mechanisms of action that potentially protect from both coronavirus disease 2019 (COVID-19) infection and COVID-19-related comorbidities. Based…[...]

Read More

COVID-19 and immune dysregulation: Genomic pathways, clinical manifestations, and therapeutic strategies

John Murphy, CEO & President, COVID-19 Long-haul Foundation Abstract SARS-CoV-2 provokes a uniquely heterogeneous and dynamic immune response that ranges from efficient viral control to fulminant hyperinflammation and prolonged immune…[...]

Read More

Just 1 in 4 Americans believe vaccine shifts are based on science, Reuters/Ipsos poll finds

By Jason Lange and Michael Erman Summary Poll shows skepticism about federal vaccine recommendations Trump administration signals fewer vaccines for young, healthy people Concerns rise over future vaccine access, especially among Democrats WASHINGTON,…[...]

Read More

Persistent Expression and Systemic Distribution of mRNA COVID-19 Biologics: A Critical Review of Clinical, Genomic, and Immunological Implications

Author: John Murphy et al. Affiliation: Strategic Clinical Research Group, USVI & Pennsylvania Corresponding Author: John Murphy Abstract Messenger RNA (mRNA) biologics developed for SARS-CoV-2 have been widely deployed under…[...]

Read More

COVID-19 Vaccination and Rhabdomyolysis: Mechanistic Hypotheses, and Clinical Implications

Introduction The global deployment of COVID-19 vaccines has been instrumental in reducing morbidity and mortality associated with SARS-CoV-2. Among the most widely adopted platforms—mRNA-based vaccines such as BNT162b2 (Pfizer-BioNTech) and…[...]

Read More